The mammogram could not see it.
The report was reassuring.
So everyone stopped looking.
Months later, the lump was still there.
Eventually it was biopsied.
Cancer.
The malpractice question sounds simple:
How can breast cancer be missed after a normal mammogram?
The more important question is different:
Why did the mammogram overrule the patient’s breast?
Screening and Diagnosis Are Not the Same Thing
Mammography is an extraordinarily important breast cancer detection tool.
But it is not perfect.
Breast density, lesion characteristics, location, age, and other factors influence detection.
More importantly, a patient with a palpable abnormality is no longer merely undergoing screening.
She has a symptom.
That changes the clinical problem.
A Test Should Answer the Question It Can Answer
A normal mammogram tells us something important.
It does not mean:
“There cannot be cancer.”
No medical test should be given more diagnostic authority than its performance characteristics justify.
If a mass persists and is clinically concerning, further evaluation may include targeted ultrasound, diagnostic breast imaging, surgical assessment, or tissue diagnosis depending on age and findings.
The exact pathway varies.
The principle does not:
Clinical-radiologic discordance needs an explanation.
The Cognitive Trap
The malpractice problem is often not ignorance.
Everyone knows mammography has false negatives.
The problem is psychological.
A test result arrives with the word:
NORMAL.
That word has tremendous power.
It converts uncertainty into reassurance.
Yet the patient can still feel the mass.
When objective data and clinical reality conflict, the job is not to choose whichever one feels more reassuring.
The job is to reconcile them.
Why ObGyns Matter
Many women see their gynecologist more reliably than they see an internist.
Breast complaints therefore commonly begin in an ObGyn office.
A gynecologist does not need to become a breast surgeon or radiologist.
But the clinician does need to recognize when the diagnostic question remains unanswered.
“She had a mammogram” is not the endpoint.
“What explains this persistent mass?” is.
The Dangerous Follow-Up Visit
Imagine that the woman returns six months later.
The mass remains.
The record says:
“Mammogram normal last year.”
That prior test can now become an anchor.
But time itself is new information.
Persistence is new information.
Growth is new information.
Changing symptoms are new information.
A previously reassuring test does not freeze the diagnostic situation permanently.
The Medical-Legal Distinction
A delayed breast cancer diagnosis does not automatically establish negligence.
Some cancers are difficult to detect.
Some lesions evolve rapidly.
Some diagnostic pathways are appropriate and still fail.
But the existence of a negative imaging study does not automatically establish appropriate care either.
The real review should ask:
Was the clinical abnormality appropriately characterized?
Was diagnostic rather than screening imaging used when indicated?
Was discordance recognized?
Was persistence addressed?
Was the patient told what should happen if the lump remained?
Preventive Ethics
The best follow-up instruction might be one sentence:
“Even if the imaging is reassuring, if you can still feel the lump, come back.”
That gives the patient a role in surveillance without shifting responsibility entirely onto her.
The MedMal Room Question
A mammogram is evidence.
A breast examination is evidence.
The patient’s report is evidence.
The passage of time is evidence.
Good medicine integrates them.
The test should inform clinical judgment.
It should not silence it.
References
Moy L, Heller SL, Bailey L, et al. ACR Appropriateness Criteria: Palpable Breast Masses. J Am Coll Radiol. 2017;14(5S).
Physician Insurers Association of America. Breast cancer and medical professional liability: patterns of delayed diagnosis. Historical closed-claims literature.
LinkedIn Tagline:
A normal mammogram does not make a persistent breast lump disappear. One of medicine’s most dangerous errors is allowing a reassuring test to overrule an unresolved clinical finding.
Hashtags: #BreastCancer #WomensHealth #Gynecology #DiagnosticError #PatientSafety #MedicalMalpractice #BreastHealth